Authors/Disclosures
|
Olivier F. Gout, MD
(Hôpital Fondation A de Rothschild)
|
Dr. Gout has nothing to disclose. |
|
Christine Lebrun Frenay, MD, FAAN
(CRCSEP Neurologie)
|
Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP. |
|
Olubunmi A. Ogunrin, MD
(University of Benin)
|
No disclosure on file |
|
Pierre Labauge, MD
|
Dr. Labauge has nothing to disclose. |
|
Emmanuelle Le Page
(CHR Pontchaillou)
|
Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. |
|
Shaun Hussain, MD
|
Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences. |
|
Pierre Clavelou, MD, PhD
(Hopital Gabriel Montpied)
|
Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. |
|
Sylvie Allouche, MD
|
No disclosure on file |